Biomarkers /

CUL1

Back to Biomarkers List
Associated Diseases

Overview

Location [1]
7q36.1
Protein [2]
Cullin-1
Synonyms [1]
-

CUL1 is altered in 0.07% of all cancers with thyroid gland papillary carcinoma, colon adenocarcinoma, low-grade glioma, NOS, pancreatic adenocarcinoma, and pilocytic astrocytoma having the greatest prevalence of alterations [3].

CUL1 GENIE Cases - Top Diseases

The most common alterations in CUL1 are CUL1-BRAF Fusion (0.06%) and CUL1-EZH2 Fusion (0.01%) [3].

CUL1 GENIE Cases - Top Alterations

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.